Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Acquisitions (2016 - 2025)

Historic Acquisitions for Phibro Animal Health (PAHC) over the last 8 years, with Q2 2025 value amounting to -$5.3 million.

  • Phibro Animal Health's Acquisitions changed N/A to -$5.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$4.3 million, marking a year-over-year decrease of 26187.99%. This contributed to the annual value of $286.5 million for FY2025, which is 863031.69% up from last year.
  • Latest data reveals that Phibro Animal Health reported Acquisitions of -$5.3 million as of Q2 2025.
  • Phibro Animal Health's 5-year Acquisitions high stood at $2.7 million for Q2 2022, and its period low was -$5.3 million during Q2 2025.
  • Its 3-year average for Acquisitions is -$403750.0, with a median of $504500.0 in 2024.
  • The largest annual percentage gain for Phibro Animal Health's Acquisitions in the last 5 years was 249318.18% (2025), contrasted with its biggest fall of 249318.18% (2025).
  • Phibro Animal Health's Acquisitions (Quarter) stood at $2.7 million in 2022, then crashed by 101.61% to -$44000.0 in 2024, then plummeted by 12056.82% to -$5.3 million in 2025.
  • Its Acquisitions stands at -$5.3 million for Q2 2025, versus $1.1 million for Q1 2025 and -$44000.0 for Q1 2024.